Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | SRC | P12931 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 1/20 | 0.50 |
| ▸ | ERN1 | O75460 | 1/20 | 0.50 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.50 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8901347 | 0.89 | KDM4E (0.58) | HPGDKDM4EHSD17B10ALDH1A1HTT | |
| SCHEMBL1006065 | 0.88 | ALDH1A1 (0.59) | HPGDKDM4EHSD17B10ALDH1A1HTT | |
| SCHEMBL21579710 | 0.86 | ERN1 (0.67) | HPGDKDM4EHSD17B10ALDH1A1HTT | |
| SCHEMBL7542596 | 0.85 | KDM4E (0.54) | HPGDKDM4EHSD17B10ALDH1A1HTT | |
| SCHEMBL1665175 | 0.84 | PTGDR2 (0.51) | HPGDKDM4EHSD17B10ALDH1A1HTT | |
| SCHEMBL11925422 | 0.83 | KDM4E (0.70) | HPGDKDM4EHSD17B10ALDH1A1HTT | |
| SCHEMBL13799146 | 0.83 | SLC6A3 (0.58) | HPGDKDM4EHSD17B10ALDH1A1HTT | |
| SCHEMBL26667032 | 0.81 | GAA (0.60) | HPGDKDM4EHSD17B10HTTSMN1; SMN2 | |
| SCHEMBL31236265 | 0.81 | PTGDR2 (0.53) | HPGDKDM4EHSD17B10ALDH1A1HTT | |
| SCHEMBL1665129 | 0.81 | SRC (0.59) | HPGDKDM4EALDH1A1LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113750917-B | High-elasticity high-temperature-resistant aerogel and preparation method thereof | 刘建浩 | 2024-05-03 | — | — | CN | claimed |
| CN-117509602-A | Preparation method of high-elasticity high-temperature-resistant aerogel | 刘建浩 | 2024-02-06 | — | — | CN | claimed |
| CN-113750917-A | High-elasticity high-temperature-resistant aerogel and preparation method thereof | 刘建浩 | 2021-12-07 | — | — | CN | claimed |
| CN-113750917-B | High-elasticity high-temperature-resistant aerogel and preparation method thereof | 刘建浩 | 2024-05-03 | — | — | CN | disclosed |
| CN-113750917-B | High-elasticity high-temperature-resistant aerogel and preparation method thereof | 刘建浩 | 2024-05-03 | — | — | CN | disclosed |
| CN-117509602-A | Preparation method of high-elasticity high-temperature-resistant aerogel | 刘建浩 | 2024-02-06 | — | — | CN | disclosed |
| CN-117509602-A | Preparation method of high-elasticity high-temperature-resistant aerogel | 刘建浩 | 2024-02-06 | — | — | CN | disclosed |
| CN-113750917-A | High-elasticity high-temperature-resistant aerogel and preparation method thereof | 刘建浩 | 2021-12-07 | — | — | CN | disclosed |
| CN-113750917-A | High-elasticity high-temperature-resistant aerogel and preparation method thereof | 刘建浩 | 2021-12-07 | — | — | CN | disclosed |
| EP-2493905-B1 | BISPHOSPHONATE COMPOUNDS FOR TREATING BONE METABOLISM DISORDERS | WARNER CHILCOTT CO LLC (PR) | 2016-11-30 | — | — | EP | disclosed |
| US-8822435-B2 | Bisphosphonate compounds | WARNER CHILCOTT COMPANY, LLC (US) | 2014-09-02 | — | — | US | disclosed |
| US-8710215-B2 | Bisphosphonate compounds | WARNER CHILCOTT COMPANY, LLC (US) | 2014-04-29 | — | — | US | disclosed |
| US-20130035482-A1 | BISPHOSPHONATE COMPOUNDS | WARNER CHILCOTT COMPANY, LLC (US) | 2013-02-07 | — | — | US | disclosed |
| US-8314081-B2 | Bisphosphonate compounds | WARNER CHILCOTT COMPANY, LLC (US) | 2012-11-20 | — | — | US | disclosed |
| EP-2493905-A1 | BISPHOSPHONATE COMPOUNDS FOR TREATING BONE METABOLISM DISORDERS | Warner Chilcott Company, LLC (PR) | 2012-09-05 | — | — | EP | disclosed |
| WO-2011056589-A1 | BISPHOSPHONATE COMPOUNDS FOR TREATING BONE METABOLISM DISORDERS | WARNER CHILCOTT COMPANY, LLC (US) | 2011-05-12 | — | — | WO | disclosed |
| US-20110098251-A1 | BISPHOSPHONATE COMPOUNDS | WARNER CHILCOTT COMPANY, LLC (US) | 2011-04-28 | — | — | US | disclosed |
| EP-0907633-B1 | NEW SYNTHETIC CATECHOL DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF | GRUENENTHAL GMBH (DE) | 2001-08-22 | — | — | EP | disclosed |
| EP-0907633-A1 | NEW SYNTHETIC CATECHOL DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF | Grünenthal GmbH (DE) | 1999-04-14 | — | — | EP | disclosed |
| WO-1997049670-A1 | NEW SYNTHETIC CATECHOL DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF | Grünenthal GmbH (DE) | 1997-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098251-A1 | BISPHOSPHONATE COMPOUNDS | BPGM, PPIP5K2, PTEN | HPGD 358/4885KDM4E 2687/4885HSD17B10 1675/4885 |
| US-20130035482-A1 | BISPHOSPHONATE COMPOUNDS | BPGM, PPIP5K2, PTEN | HPGD 358/4885KDM4E 2687/4885HSD17B10 1675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.